Trials show China's mRNA COVID-19 vaccine safe, effective
BEIJING, Jan. 25 (Xinhua) -- A China-developed mRNA COVID-19 vaccine has been shown to be safe, well-tolerated and effective in early-stage human trials, according to a study published Tuesday in the Lancet Microbe journal.
The vaccine ARCoV, which encodes the SARS-CoV-2 spike protein receptor-binding domain, was jointly developed by the Academy of Military Medical Sciences, Suzhou Abogen Biosciences and Yunnan-